COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 60,830 | 1,583,700 | SH | | SOLE | | 1,583,700 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 10 | 156 | SH | | SOLE | | 156 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 2,148 | 64,900 | SH | | SOLE | | 64,900 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 3,224 | 111,800 | SH | | SOLE | | 111,800 | 0 | 0 |
Accelerate Diagnostics, Inc. | Common | 00430H102 | 2,490 | 120,000 | SH | | SOLE | | 120,000 | 0 | 0 |
Acceleron Pharma, Inc. | Common | 00434H108 | 1,390 | 54,450 | SH | | SOLE | | 54,450 | 0 | 0 |
Achillion Pharmaceuticals, Inc. | Common | 00448Q201 | 1,833 | 443,851 | SH | | SOLE | | 443,851 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | Common | 00548A106 | 2,121 | 125,504 | SH | | SOLE | | 125,504 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 2,294 | 566,368 | SH | | SOLE | | 566,368 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. | Note 2.00% 5/15/19 | 00767EAB8 | 9,263 | 13,000,000 | PRN | | SOLE | | 13,000,000 | 0 | 0 |
Affimed NV | Common | N01045108 | 530 | 294,213 | SH | | SOLE | | 294,213 | 0 | 0 |
Akorn, Inc. | Common | 009728106 | 7,154 | 327,735 | SH | | SOLE | | 327,735 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 97,379 | 795,905 | SH | | SOLE | | 795,905 | 0 | 0 |
Allergan plc | Common | G0177J108 | 91,162 | 434,086 | SH | | SOLE | | 434,086 | 0 | 0 |
Allergan plc | Preferred Convertible | G0177J116 | 3,812 | 5,000 | SH | | SOLE | | 5,000 | 0 | 0 |
Alliqua BioMedical, Inc. | Common | 019621200 | 974 | 1,650,000 | SH | | SOLE | | 1,650,000 | 0 | 0 |
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 1,772 | 173,600 | SH | | SOLE | | 173,600 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 9,135 | 243,995 | SH | | SOLE | | 243,995 | 0 | 0 |
AmerisourceBergen Corporation | Common | 03073E105 | 25,856 | 330,687 | SH | | SOLE | | 330,687 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 47,027 | 321,640 | SH | | SOLE | | 321,640 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 2,081 | 418,730 | SH | | SOLE | | 418,730 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y407 | 2,312 | 811,227 | SH | | SOLE | | 811,227 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 9,079 | 639,370 | SH | | SOLE | | 639,370 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 12,671 | 463,800 | SH | | SOLE | | 463,800 | 0 | 0 |
Auris Medical Holding AG | Common | H03579101 | 829 | 774,504 | SH | | SOLE | | 774,504 | 0 | 0 |
Becton, Dickinson and Co. | Common | 075887109 | 10,443 | 63,078 | SH | | SOLE | | 63,078 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 3,543 | 116,707 | SH | | SOLE | | 116,707 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 817 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 152,382 | 537,350 | SH | | SOLE | | 537,350 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 47,438 | 572,645 | SH | | SOLE | | 572,645 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 3,045 | 49,345 | SH | | SOLE | | 49,345 | 0 | 0 |
Cardinal Health, Inc. | Common | 14149Y108 | 10,975 | 152,500 | SH | | SOLE | | 152,500 | 0 | 0 |
Care Capital Properties, Inc. | Common | 141624106 | 8,626 | 345,022 | SH | | SOLE | | 345,022 | 0 | 0 |
Celgene Corporation | Common | 151020104 | 163,195 | 1,409,889 | SH | | SOLE | | 1,409,889 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B103 | 375 | 105,800 | SH | | SOLE | | 105,800 | 0 | 0 |
Cellectis S.A. | Sponsored ADR | 15117K103 | 5,259 | 310,250 | SH | | SOLE | | 310,250 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 22,604 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 9,722 | 127,600 | SH | | SOLE | | 127,600 | 0 | 0 |
Chimerix, Inc. | Common | 16934W106 | 1,421 | 308,892 | SH | | SOLE | | 308,892 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 1,378 | 132,472 | SH | | SOLE | | 132,472 | 0 | 0 |
Cigna Corporation | Common | 125509109 | 11,525 | 86,400 | SH | | SOLE | | 86,400 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 2,534 | 90,000 | SH | | SOLE | | 90,000 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 1,140 | 203,935 | SH | | SOLE | | 203,935 | 0 | 0 |
CVS Health Corporation | Common | 126650100 | 32,502 | 411,891 | SH | | SOLE | | 411,891 | 0 | 0 |
CytomX Therapeutics, Inc. | Common | 23284F105 | 8,309 | 756,090 | SH | | SOLE | | 756,090 | 0 | 0 |
DBV Technologies S.A. | Sponsored ADR | 23306J101 | 2,305 | 65,600 | SH | | SOLE | | 65,600 | 0 | 0 |
Dermira, Inc. | Common | 24983L104 | 5,011 | 165,200 | SH | | SOLE | | 165,200 | 0 | 0 |
Diplomat Pharmacy, Inc. | Common | 25456K101 | 1,641 | 130,223 | SH | | SOLE | | 130,223 | 0 | 0 |
Dynavax Technologies Corporation | Common | 268158201 | 1,363 | 345,050 | SH | | SOLE | | 345,050 | 0 | 0 |
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 6,059 | 7,000,000 | PRN | | SOLE | | 7,000,000 | 0 | 0 |
Eli Lilly & Company | Common | 532457108 | 36,268 | 493,100 | SH | | SOLE | | 493,100 | 0 | 0 |
Endo International plc | Shares | G30401106 | 15,063 | 914,548 | SH | | SOLE | | 914,548 | 0 | 0 |
Endologix, Inc. | Common | 29266S106 | 2,212 | 386,750 | SH | | SOLE | | 386,750 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 4,840 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 1,287 | 102,800 | SH | | SOLE | | 102,800 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 8,225 | 551,647 | SH | | SOLE | | 551,647 | 0 | 0 |
Flamel Technologies SA | Sponsored ADR | 338488109 | 6,486 | 624,288 | SH | | SOLE | | 624,288 | 0 | 0 |
Flex Pharma, Inc. | Common | 33938A105 | 856 | 162,124 | SH | | SOLE | | 162,124 | 0 | 0 |
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 10,327 | 930,398 | SH | | SOLE | | 930,398 | 0 | 0 |
Forward Pharma A/S | Sponsored ADR | 34986J105 | 2,050 | 136,547 | SH | | SOLE | | 136,547 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 7,429 | 115,738 | SH | | SOLE | | 115,738 | 0 | 0 |
GenMark Diagnostics, Inc. | Common | 372309104 | 1,143 | 93,349 | SH | | SOLE | | 93,349 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 181,183 | 2,530,131 | SH | | SOLE | | 2,530,131 | 0 | 0 |
GlaxoSmithKline plc | Sponsored ADR | 37733W105 | 13,825 | 359,000 | SH | | SOLE | | 359,000 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 5,510 | 381,300 | SH | | SOLE | | 381,300 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 655 | 73,400 | SH | | SOLE | | 73,400 | 0 | 0 |
Grifols, S.A. | Sponsored ADR | 398438408 | 2,668 | 166,000 | SH | | SOLE | | 166,000 | 0 | 0 |
Halozyme Therapeutics, Inc. | Common | 40637H109 | 1,976 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
HCA Holdings, Inc. | Common | 40412C101 | 14,081 | 190,232 | SH | | SOLE | | 190,232 | 0 | 0 |
HCP, Inc. | Common | 40414L109 | 1,352 | 45,500 | SH | | SOLE | | 45,500 | 0 | 0 |
Healthcare Realty Trust, Inc. | Common | 421946104 | 2,062 | 68,000 | SH | | SOLE | | 68,000 | 0 | 0 |
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,339 | 46,000 | SH | | SOLE | | 46,000 | 0 | 0 |
Horizon Pharma plc | Shares | G4617B105 | 2,636 | 162,900 | SH | | SOLE | | 162,900 | 0 | 0 |
Humana Inc. | Common | 444859102 | 33,624 | 164,800 | SH | | SOLE | | 164,800 | 0 | 0 |
ICON plc | Shares | G4705A100 | 5,414 | 72,000 | SH | | SOLE | | 72,000 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 15,521 | 132,352 | SH | | SOLE | | 132,352 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 31,570 | 246,560 | SH | | SOLE | | 246,560 | 0 | 0 |
Immunomedics, Inc. | Note 4.75% 2/15/20 | 452907AK4 | 3,960 | 4,000,000 | PRN | | SOLE | | 4,000,000 | 0 | 0 |
Impax Laboratories, Inc. | Common | 45256B101 | 1,647 | 124,335 | SH | | SOLE | | 124,335 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 88,284 | 880,461 | SH | | SOLE | | 880,461 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 942 | 71,842 | SH | | SOLE | | 71,842 | 0 | 0 |
iShares Nasdaq Biotechnology ETF | ETF | 464287556 | 15,304 | 57,670 | SH | | SOLE | | 57,670 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 36,134 | 331,411 | SH | | SOLE | | 331,411 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 51,062 | 443,212 | SH | | SOLE | | 443,212 | 0 | 0 |
Juno Therapeutics, Inc. | Common | 48205A109 | 1,073 | 56,900 | SH | | SOLE | | 56,900 | 0 | 0 |
Karyopharm Therapeutics Inc. | Common | 48576U106 | 4,703 | 500,324 | SH | | SOLE | | 500,324 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 6,399 | 136,212 | SH | | SOLE | | 136,212 | 0 | 0 |
Mallinckrodt plc | Shares | G5785G107 | 3,084 | 61,900 | SH | | SOLE | | 61,900 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 2,107 | 15,000 | SH | | SOLE | | 15,000 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 12,395 | 1,007,717 | SH | | SOLE | | 1,007,717 | 0 | 0 |
The Medicines Company | Common | 584688105 | 26,189 | 771,638 | SH | | SOLE | | 771,638 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 44,378 | 623,030 | SH | | SOLE | | 623,030 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 70,547 | 1,198,349 | SH | | SOLE | | 1,198,349 | 0 | 0 |
Merus B.V. | Common | N5749R100 | 10,115 | 479,150 | SH | | SOLE | | 479,150 | 0 | 0 |
Molina Healthcare, Inc. | Common | 60855R100 | 21,842 | 402,541 | SH | | SOLE | | 402,541 | 0 | 0 |
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 4,614 | 306,600 | SH | | SOLE | | 306,600 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 43,321 | 1,135,552 | SH | | SOLE | | 1,135,552 | 0 | 0 |
Myovant Sciences Ltd. | Common | G637AM102 | 4,976 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Nabriva Therapeutics AG | Sponsored ADR | 62957M104 | 2,083 | 350,000 | SH | | SOLE | | 350,000 | 0 | 0 |
Natera, Inc. | Common | 632307104 | 10,332 | 882,358 | SH | | SOLE | | 882,358 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 15,165 | 391,869 | SH | | SOLE | | 391,869 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 5,561 | 567,997 | SH | | SOLE | | 567,997 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 18,123 | 248,800 | SH | | SOLE | | 248,800 | 0 | 0 |
Novavax, Inc. | Common | 670002104 | 719 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 14,336 | 458,616 | SH | | SOLE | | 458,616 | 0 | 0 |
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 11,744 | 762,581 | SH | | SOLE | | 762,581 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 3,104 | 37,300 | SH | | SOLE | | 37,300 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 37,244 | 1,146,689 | SH | | SOLE | | 1,146,689 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 10,062 | 530,672 | SH | | SOLE | | 530,672 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 5,804 | 4,145,958 | SH | | SOLE | | 4,145,958 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 5,622 | 102,000 | SH | | SOLE | | 102,000 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 7,988 | 260,200 | SH | | SOLE | | 260,200 | 0 | 0 |
Quorum Health Corporation | Common | 74909E106 | 172 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 68,890 | 187,666 | SH | | SOLE | | 187,666 | 0 | 0 |
Retrophin, Inc. | Common | 761299106 | 3,179 | 167,949 | SH | | SOLE | | 167,949 | 0 | 0 |
The RMR Group Inc. | Class A | 74967R106 | 294 | 7,441 | SH | | SOLE | | 7,441 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 13,455 | 550,990 | SH | | SOLE | | 550,990 | 0 | 0 |
Sage Therapeutics, Inc. | Common | 78667J108 | 2,757 | 54,000 | SH | | SOLE | | 54,000 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 12,334 | 305,000 | SH | | SOLE | | 305,000 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 12,791 | 466,300 | SH | | SOLE | | 466,300 | 0 | 0 |
Senior Housing Properties Trust | Shares | 81721M109 | 12,239 | 646,554 | SH | | SOLE | | 646,554 | 0 | 0 |
Shire plc | Sponsored ADR | 82481R106 | 39,428 | 231,413 | SH | | SOLE | | 231,413 | 0 | 0 |
Spark Therapeutics, Inc. | Common | 84652J103 | 1,213 | 24,300 | SH | | SOLE | | 24,300 | 0 | 0 |
SPDR S&P Biotech ETF | ETF | 78464A870 | 10,595 | 179,000 | SH | | SOLE | | 179,000 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 2,441 | 164,500 | SH | | SOLE | | 164,500 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 775 | 192,322 | SH | | SOLE | | 192,322 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 28,600 | 788,958 | SH | | SOLE | | 788,958 | 0 | 0 |
TherapeuticsMD, Inc. | Common | 88338N107 | 1,080 | 187,100 | SH | | SOLE | | 187,100 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 19,912 | 141,120 | SH | | SOLE | | 141,120 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 6,215 | 88,400 | SH | | SOLE | | 88,400 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 1,350 | 241,021 | SH | | SOLE | | 241,021 | 0 | 0 |
United Therapeutics Corporation | Common | 91307C102 | 13,353 | 93,100 | SH | | SOLE | | 93,100 | 0 | 0 |
UnitedHealth Group Inc. | Common | 91324P102 | 39,357 | 245,920 | SH | | SOLE | | 245,920 | 0 | 0 |
Universal Health Services, Inc. | Class B | 913903100 | 15,614 | 146,780 | SH | | SOLE | | 146,780 | 0 | 0 |
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 2,788 | 192,000 | SH | | SOLE | | 192,000 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 11,003 | 175,991 | SH | | SOLE | | 175,991 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 76,138 | 1,033,503 | SH | | SOLE | | 1,033,503 | 0 | 0 |
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | 12,036 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 1,432 | 21,400 | SH | | SOLE | | 21,400 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 526 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 5,390 | 700,000 | SH | | SOLE | | 700,000 | 0 | 0 |
Zafgen, Inc. | Common | 98885E103 | 42 | 13,307 | SH | | SOLE | | 13,307 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 10,557 | 102,300 | SH | | SOLE | | 102,300 | 0 | 0 |